Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Team Approach: Diagnosis and Management of Pediatric Pelvic Ewing Sarcoma.

JBJS reviews·2026
Same author

Sclerosing Rhabdomyosarcoma Arising in Desmoid Fibromatosis 17 Years After Therapeutic Radiation.

JBJS case connector·2026
Same author

Current Treatment Strategies for Diffuse Tenosynovial Giant Cell Tumor: A Review of the Literature.

JB & JS open access·2026
Same author

Role of extracellular matrix in chordoma progression and therapeutic resistance.

Critical reviews in oncology/hematology·2025
Same author

Characteristics of histiocytic neoplasms presenting as breast masses.

British journal of haematology·2025
Same author

Tumor Genomics, Metastatic Patterns, and Prognosis in Leiomyosarcoma: A Single-Center Retrospective Cohort Study.

Cancers·2025

Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
07:43

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

4.6K

Bone Sarcoma Pathology: Diagnostic Approach for Optimal Therapy.

Andrew E Rosenberg1

  • 1From the Miller School of Medicine, University of Miami, Miami, FL.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|June 1, 2017
PubMed
Summary
This summary is machine-generated.

Diagnosing malignant bone tumors, or bone sarcomas, is complex due to their rarity and varied appearance. Accurate pathology requires integrating clinical data and identifying molecular changes for effective patient treatment.

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K

Related Experiment Videos

Last Updated: Mar 1, 2026

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
07:43

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

4.6K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K

Area of Science:

  • Oncology
  • Pathology
  • Surgical Pathology

Background:

  • Malignant bone tumors present diagnostic challenges in surgical pathology.
  • Primary bone sarcomas are rare, morphologically diverse, and biologically complex, hindering pathologist expertise.
  • Accurate diagnosis necessitates integrating clinical, radiologic, and molecular information.

Purpose of the Study:

  • To highlight the complexities in diagnosing malignant bone tumors.
  • To emphasize the critical role of pathologists in accurate diagnosis, grading, and molecular profiling.
  • To outline the essential components of pathology reports for both biopsy and resected bone sarcoma specimens.

Main Methods:

  • Review of diagnostic challenges in bone sarcoma pathology.
  • Integration of clinical and radiologic data in pathologic interpretation.
  • Identification of critical molecular aberrations for specific diagnoses.

Main Results:

  • Pathologic interpretation of bone sarcomas is challenging due to heterogeneity and rarity.
  • Molecular aberrations are increasingly critical for accurate sarcoma diagnosis.
  • Pathologists guide treatment by providing accurate diagnoses, grades, and molecular information.

Conclusions:

  • Accurate diagnosis of bone sarcomas requires comprehensive integration of diverse data.
  • Pathologists play a vital role in optimizing patient treatment through precise diagnostic reporting.
  • Molecular analysis is essential for specific diagnoses and targeted therapies in bone sarcomas.